Barclays
IDYA icon

Barclays’s IDEAYA Biosciences IDYA Stock Holding History

Barclays’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
16,284
+304
+2% +$9.31K ﹤0.01% 3106
2026
Q1 		$532K Sell
15,980
-219,892
-93% -$7.38M ﹤0.01% 3160
2025
Q4 		$8.15M Sell
235,872
-14,509
-6% -$463K ﹤0.01% 1841
2025
Q3 		$6.81M Sell
250,381
-70,785
-22% -$1.71M ﹤0.01% 1973
2025
Q2 		$6.75M Buy
321,166
+135,800
+73% +$2.61M ﹤0.01% 1861
2025
Q1 		$3.04M Sell
185,366
-13,390
-7% -$285K ﹤0.01% 2313
2024
Q4 		$5.11M Buy
198,756
+17,586
+10% +$498K ﹤0.01% 2150
2024
Q3 		$5.74M Buy
181,170
+118,438
+189% +$4.49M ﹤0.01% 1972
2024
Q2 		$2.2M Sell
62,732
-7,234
-10% -$286K ﹤0.01% 2065
2024
Q1 		$3.07M Sell
69,966
-106,474
-60% -$4.58M ﹤0.01% 2211
2023
Q4 		$6.28M Buy
176,440
+90,114
+104% +$2.69M ﹤0.01% 1906
2023
Q3 		$2.33M Buy
86,326
+13,049
+18% +$331K ﹤0.01% 1796
2023
Q2 		$1.72M Buy
73,277
+11,020
+18% +$227K ﹤0.01% 1974
2023
Q1 		$855K Sell
62,257
-32,086
-34% -$535K ﹤0.01% 2856
2022
Q4 		$1.71M Buy
94,343
+23,735
+34% +$399K ﹤0.01% 2368
2022
Q3 		$1.05M Buy
70,608
+68,244
+2,887% +$886K ﹤0.01% 2190
2022
Q2 		$33K Sell
2,364
-3,078
-57% -$34.2K ﹤0.01% 4205
2022
Q1 		$61K Sell
5,442
-34,318
-86% -$506K ﹤0.01% 4033
2021
Q4 		$940K Buy
39,760
+26,173
+193% +$608K ﹤0.01% 2872
2021
Q3 		$347K Buy
13,587
+1,540
+13% +$36K ﹤0.01% 3362
2021
Q2 		$252K Sell
12,047
-2,809
-19% -$57.7K ﹤0.01% 3440
2021
Q1 		$348K Buy
14,856
+9,616
+184% +$186K ﹤0.01% 3410
2020
Q4 		$73K Sell
5,240
-2,036
-28% -$27.6K ﹤0.01% 4256
2020
Q3 		$91K Buy
7,276
+648
+10% +$8.03K ﹤0.01% 4307
2020
Q2 		$94K Buy
+6,628
New +$52.2K ﹤0.01% 4561

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Barclays's IDYA Position: Q2 2026 in Review

Barclays increased its IDEAYA Biosciences (IDYA) stake by 1.9% in Q2 2026, buying an estimated $9.31K and bringing the position to 16,284 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Barclays first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.15M in Q4 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Barclays held 16,284 shares of IDEAYA Biosciences worth $607K as of Q2 2026.
  • Barclays bought 304 IDEAYA Biosciences shares in Q2 2026, an estimated $9.31K.
  • IDEAYA Biosciences made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3106 holding.
  • Barclays first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • Barclays's IDEAYA Biosciences position peaked at $8.15M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.